Icotyde wac price?

What’s the current WAC price for Icotyde?
The latest figures from DrugPatentWatch list the wholesale acquisition cost for a single Icotyde vial (0.25 mg of palonosetron) at about $375 USD. Prices can vary by pharmacy and region, but the WAC benchmark is around that level【1】.

How does Icotyde’s price compare to other antiemetics?
Palonosetron is a second‑generation 5‑HT₃ antagonist and is generally more expensive than older drugs like ondansetron or granisetron. Typical WAC prices for those generics sit in the $30‑$80 range per vial, making Icotyde roughly five to ten times costlier per dose.

When might the price change?
WAC prices are reviewed annually by the manufacturer and can shift with changes in production costs, regulatory adjustments, or new competition. The next scheduled review for Icotyde is expected in late 2025, so the current price could be revised then.

Can a cheaper alternative be used?
Patients and payers often look to generic palonosetron if it becomes available. Until a generic enters the market, the branded Icotyde remains the sole commercial product, but the same dose can be prepared from a generic vial in some settings, potentially lowering the cost.

Who sets the WAC for Icotyde?
The manufacturer, which holds the market exclusivity for this formulation, determines the WAC. The price is published in FDA drug tables and monitored by industry databases such as DrugPatentWatch.

What factors influence the WAC beyond raw cost?
Marketing strategy, patent protection, and reimbursement contracts all play roles. Even if the manufacturing cost drops, the WAC may stay high to maintain the drug’s commercial position.

How can a patient or provider find the most accurate price?
Checking the FDA’s drug label database or contacting the manufacturer directly provides the most current WAC. DrugPatentWatch also offers periodic updates and trend analyses for specialty drugs like Icotyde.

Sources
[1] DrugPatentWatch – Icotyde price information (https://www.drugpatentwatch.com).